Dominic Wall

[ProsTIC @pros_tic]

3️⃣5️⃣0️⃣+ attendees 😎
2️⃣6️⃣+ countries 🌏
3️⃣8️⃣+ speakers 🗣️
3️⃣ amazing days 🤩

This is #PSMA #theranostics 🚀

This is next-gen #PrecisionOncology in Practice 🎯

This is #ProsTIC24 💪

@PeterMacCC @DrMHofman

[Michael Hofman @DrMHofman]

Our Terbium-161 PSMA clinical trial reached full recruitment today, 10 months ahead of schedule. Incredible effort by @PeterMacCC and collaboration with @Isotopia_il and @PCF_Science

#TeamScience

Contributing to 2 PhDs
@ButeauJames @LouiseKostos
@AzadOncology @pros_tic
@MHaskali

[Rasko Lab @RaskoLab]

Well deserved accolade to the amazing Dr Dominic Wall from Australia 🇦🇺 recognizing his mentoring. Nominated by Dr Gabrielle O’Sullivan from @SydneyLHD

Dominic saw the future of cell and gene therapies long before many others @ISCTglobal @ISCT_ESP

[Rasko Lab @RaskoLab]

BFFs

[Dominic Wall @DominicCellTher]

@RaskoLab @SydneyLHD @ISCTglobal @ISCT_ESP John- you are much too kind!

[Alicia Didsbury @AliciaD_nz]

Collaboration and continuity. ISCT ESP mentoring work group presents the mentoring reception. Hearing from our mentor champions @KlamerGuy @DominicCellTher and Dominique Farge

[Michael Hofman @DrMHofman]

PSMA PET/CT (Ga-68 and F-18) will be reimbursed in Australia from 01 Jul 22 for staging intermediate-to-high risk and biochemical recurrence. Direct result of Australian led research @PeterMacCC @ANZUPtrials #ARTnet

[Peter Mac Cancer Centre @PeterMacCC]

Building international partnerships with leaders in Cellular Immunotherapy across time zones this morning with @UofPenn and @PeterMacCC experts sharing up-to-the-minute research to improve treatments for cancer patients across the world. @PeterMacCoE

[Shankar Siva @_ShankarSiva]

And we are off at the inaugural #prostic22! The very first talk by @RenuEapen … great to see a live / virtual hybrid audience in Melbourne 👏🏽👏🏽 well done @DrMHofman and colleagues in organising this exceptional meeting #pcsm

[Shelley Dolan @ShelleyDolan2]

Wonderful talk on rad onc in prostate cancer by Prof Hruby and even the late great John Lennon quoted!!#ProsTIC22 rocks🎉🎉

[Dominic Wall @DominicCellTher]

What a milestone! Demonstrates that even with all of the pandemic disruptions, we can still do great tech transfers on budget and on time...

[Cell Therapies Pty Ltd @CellTherapies_]

Cell Therapies Pty Ltd has received TGA approval to manufacture @Novartis CAR-T therapy, Kymriah® at @PeterMacCC in Australia. This will bring faster access to treatment for eligible Australians with life-threatening blood cancers.
https://t.co/09DES0Bif3

[Michael Dickinson @mike_dickinson1]

Are #CART cells better than transplantation(ASCT) for patients with relapse within 12m of first treatment for diffuse large B-cell #lymphoma? We don't know. That's why Peter Mac and others in Oz have the BELINDA trial which randomises CART or ASCT. https://t.co/wgx6uxUV9C

[Novartis Cancer @NovartisCancer]

Novartis announced CAR-T reimbursement in Australia today for eligible adult patients with relapsed or refractory diffuse large B cell lymphoma #DLBCL, alongside a manufacturing agreement with @CellTherapies_ to locally produce CAR-T out of @PeterMacCC #NovartisNews

[Peter Mac Cancer Centre @PeterMacCC]

Today's exciting CAR T-Cell Therapy developments mean both wider access for #bloodcancer patients and commercial manufacture is coming to Australia - at @CellTherapies_ within Peter Mac. Read more: https://t.co/I3TWAMyRF5

[Peter Mac Cancer Centre @PeterMacCC]

Peter Mac's Elves (aka the Social Work Department) have been busy packing hampers to give to patients doing it tough this Christmas. The team has collected 50 hampers with all items donated by staff from across Peter Mac. Well done team!

[Dominic Wall @DominicCellTher]

Evaluable MRD results were also compelling

[Michael Dickinson @mike_dickinson1]

The results for CART in #myeloma in an incredibly heavily treated population were simply stunning in this trial at #ASH19 https://t.co/cLoIa8ro4p #myelomasm You just don’t see waterfall plots like that in MM very often!

[Michael Dickinson @mike_dickinson1]

Real world data in #CART ! Finally some data from centres that use #Kymriah and #yescarta poster 1599 #ASH19 #lymsm Largely reassuring ! https://t.co/GkDrUQINNU

[Peter Mac Cancer Centre @PeterMacCC]

Delighted to welcome EU ambassadors to Peter Mac today for an introduction to the world-leading Parkville biomedical precinct. The delegation met with our Chief Executive Shelley Dolan and precinct partners to discuss key research and training links between Parkville and the EU.

[Dominic Wall @DominicCellTher]

@ngaire_elwood @jmacpher @TGAgovau All credit to our friends from TGA @TGAgovau and at the OGTR who were such good sports for the case study discussion

[Dominic Wall @DominicCellTher]

@jmacpher @TGAgovau @ngaire_elwood I hope it was good clean fun!